logo
Cannabis use doubles the risk of dying from heart disease, study finds

Cannabis use doubles the risk of dying from heart disease, study finds

Euronews18-06-2025
People who use cannabis or its synthetic cousin, cannabinoids, are twice as likely to die from heart problems as those who abstain from the drugs, new research has found.
Recreational cannabis use remains illegal in most of Europe, but it is the region's most commonly used drug. An estimated 8.4 per cent of adults – 24 million people – used cannabis in the past year, according to the European Union Drugs Agency (EUDA).
Cannabis is generally stronger and more diverse than in past decades, with users having a choice between smoking marijuana, edibles, cannabis concentrates, and cannabinoids, which are synthetic psychoactive drugs with a high concentration of
Tetrahydrocannabinol (THC), the active ingredient in cannabis that makes people feel high.
That has prompted concern about the potential health consequences of modern cannabis – and the new study, published in the journal Heart, is the latest to show they carry weight.
In addition to the doubled mortality risks, cannabis use is tied to a 20 per cent higher risk of stroke and a 29 per cent higher risk of heart attacks or other types of acute coronary syndrome, which is when blood flow to the heart is severely restricted, the study found.
The findings raise 'serious questions about the assumption that cannabis imposes little cardiovascular risk,' Stanton Glantz and Dr Lynn Silver, researchers at the University of California at San Francisco who were not involved with the study, said in a written comment.
For the analysis, a French research team assessed real-world data from 24 studies conducted between 2016 and 2023.
Most participants were between the ages of 19 and 59, and cannabis users were more likely to be younger and male compared with people who did not use the drug.
Notably, most of the studies were observational, meaning researchers can't say that cannabis use causes heart problems directly. There was also a high risk of bias in most of the studies.
More research is needed to understand exactly how cannabis is linked to heart problems, and whether the risks differ based on the type of cannabis someone uses.
Despite the limitations, the study authors said their analysis is among the most comprehensive yet to probe the possible link between cannabis and heart problems in the real world.
Glantz and Silver pushed for health warnings on cannabis products and protections against secondhand smoke exposure, particularly as countries relax their cannabis laws and the drug becomes more easily available.
'Cannabis needs to be incorporated into the framework for prevention of clinical cardiovascular disease,' they said.
British lawmakers have voted to decriminalise abortion in England and Wales, following concerns about the number of women who are investigated for terminated pregnancies.
The House of Commons approved an amendment — it passed 379-317 — to a broader crime bill that would prevent women from being criminally punished under an antiquated law dating back to the mid-19th century.
Abortion has been legal in England and Wales for almost six decades but only up to 24 weeks and with the approval of two doctors.
The amendment means that women who terminate their pregnancy after 24 weeks will no longer be investigated by the police. Medical professionals or anybody assisting a woman with an abortion outside outside the 24-week limit could still face prosecution.
Labour MP Tonia Antoniazzi, the Labour member of Parliament who introduced one of the amendments, said the change was needed because police have investigated more than 100 women for suspected illegal abortions over the past five years, including some who suffered natural miscarriages and stillbirths.
'This piece of legislation will only take women out of the criminal justice system because they are vulnerable and they need our help,' she said. 'Just what public interest is this serving? This is not justice, it is cruelty and it has got to end.'
The House of Commons will now need to pass the crime bill, which is expected, before it goes to the House of Lords, where it can be delayed but not blocked.
Under current law, doctors can legally carry out abortions in England, Scotland and Wales up to 24 weeks, and beyond that under special circumstances, such as when the life of the mother is in danger. Abortion in Northern Ireland was decriminalised in 2019.
Changes in the law implemented during the COVID-19 pandemic allow women to receive abortion pills through the mail and terminate their own pregnancies at home within 10 weeks of conception.
That has led to a handful of widely publicised cases in which women were prosecuted for illegally obtaining abortion pills and using them to end their own pregnancies after 24 weeks or more.
Anti-abortion groups opposed the measures, arguing it would open the door to abortion on demand at any stage of pregnancy.
'Unborn babies will have any remaining protection stripped away, and women will be left at the mercy of abusers,' said Alithea Williams, public policy manager for the Society for the Protection of Unborn Children, which describes itself as the UK's biggest pro-life campaign group.
The debate came after recent prosecutions have galvanised support to repeal parts of the 1861 Offences Against the Person Act.
In one case, a mother of three was sentenced to more than two years in prison in 2023 for medically inducing an abortion about eight months into her pregnancy.
Carla Foster, 45, was released about a month later by an appeals court that reduced her sentence. Judge Victoria Sharp said that case called for 'compassion, not punishment' and there was no useful purpose in jailing her.
Last month, a jury acquitted Nicola Packer on a charge of unlawfully self-administering poison or a noxious thing with intent to procure a miscarriage. Packer, who took abortion medicine when she was about 26 weeks pregnant, testified that she did not know she had been pregnant more than 10 weeks.
Supporters of the bill said it was a landmark reform that would keep women from going to prison for ending their pregnancy.
'At a time when we're seeing rollbacks on reproductive rights, most notably in the United States, this crucial milestone in the fight for reproductive rights sends a powerful message that our lawmakers are standing up for women,' said Louise McCudden of MSI Reproductive Choices.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Taliban deny British couple held in Afghan prison are being mistreated
Taliban deny British couple held in Afghan prison are being mistreated

Euronews

time2 days ago

  • Euronews

Taliban deny British couple held in Afghan prison are being mistreated

The Taliban said on Wednesday that efforts to free a British couple from an Afghan prison are under way and denied that their rights are being violated, despite concerns from their relatives and UN officials. Peter and Barbie Reynolds, who are in their 70s, were arrested in early February after being taken from their home in central Bamiyan province to the capital, Kabul. The couple run an organisation that provides education and training programmes. Family members in the UK have said they are being mistreated and held on undisclosed charges. UN rights experts on Monday called for the pair's release, warning that their health was deteriorating rapidly and that they were at risk of irreparable harm or even death. The Taliban's Foreign Minister Amir Khan Muttaqi rejected concerns about rights violations. "They are in constant contact with their families," Muttaqi told reporters at a media briefing in Kabul on Wednesday. "Consular services are available. Efforts are underway to secure their release. These steps have not yet been completed. Their human rights are being respected. They are being given full access to treatment, contact and accommodation," he added. But Muttaqi did not outline what steps were being taken to secure the couple's release. According to the UN experts, the Reynolds' spell in detention included time in a maximum-security facility and later in underground cells before being moved to above-ground cells at the General Directorate of Intelligence in Kabul. Peter needs heart medication and, during his detention, suffered two eye infections as well as intermittent tremors in his head and down his left arm. He recently collapsed, the UN statement said, while Barbie suffers from anaemia and remains weak. "It is inhumane to keep them locked up in such degrading conditions and more worrying when their health is so fragile," said the UN experts, who called for their immediate transfer to a civilian hospital. The couple's adult children said in a statement on Sunday that Peter and Barbie have no bed or furniture and sleep on a mattress on the floor. Peter's face is red, peeling and bleeding, likely due to the return of skin cancer that urgently needs removing, they said. "We, their four adult children, have written privately to the Taliban leadership twice, pleading for them to uphold their beliefs of compassion, mercy, fairness, and human dignity," the children said. Officials from the UK Foreign Office (FCDO) visited the couple last week, the family said. "We are supporting the family of two British nationals who are detained in Afghanistan," an FCDO spokesperson said.

Why has the UK banned imports of French and Italian cheeses?
Why has the UK banned imports of French and Italian cheeses?

Local France

time2 days ago

  • Local France

Why has the UK banned imports of French and Italian cheeses?

Bad news for UK residents who like iconic French cheeses such as artisan-produced brie, roquefort and reblochon or Italian classics such as pecorino ... these will no longer be available after the UK banned their imports from France or Italy. However if you are in those countries - or any other EU country - you can enjoy them to your heart's content. So what's going on? The UK's agriculture ministry Defra says that all imports of cheeses made in France or Italy with unpasturised milk are now banned. This affects any cheese made with raw milk or unpasturised milk - including some of France's most famous cheeses such as Vacherin, Roquefort, Mimolette and Tomme. Brie made by small artisan producers is likely to be unpasturised, although factory-produced brie can be made with pasturised milk. Advertisement It affects fewer Italian cheeses as the big names such as Parmesan are made with pasturised milk, but artisan-produced mozzarella is often made with raw milk, as is pecorino. You can find a full list of the affected cheeses here . Any cheeses produced before May 23rd are exempt, if the importer can produce the necessary paperwork - meaning that shortages will become apparent gradually, as some aged cheeses will continue to be imported over the next few months. The rules mostly affect commercial imports, but theoretically also apply to holidaymakers wanting to bring back a wheel of lovely, stinky European cheese. All of the above cheeses remain on sale throughout the EU. So why the UK ban? It's due to an outbreak of a cattle disease with the imaginative name of Lumpy Skin Disease (LSD) which, you will be surprised to hear, causes lumps on the skin of affected cattle. In France the disease is known as dermatose nodulaire contagieuse (DNC). It is spread by the bites of flies and mosquitoes. Italy confirmed its first case in Sardinia on June 21st, 2025, leading the UK to revoke Italy's LSD-free status and suspend unpasturised imports. France reported its first LSD case near Chambéry on June 29th. Quarantine zones are in place in the affected areas with a vaccination programme for the cattle, but cheese sales have not been suspended. The UK's import ban also affects the import of live cattle. Can Lumpy Skin Disease be spread by eating cheese? No, there is no risk to humans from eating cheese that has been produced by a cow suffering from LSD, and in fact humans cannot get LSD under any circumstances. The UK government says that it is acting to prevent the spread of the virus among British cattle - hence the ban on live cattle imports. It says that the virus can survive in raw milk, including cheese made with raw milk. So if a British cow ate a brie sandwich then it could get Lumpy Skin Disease. That sounds like a small risk? Frustrated cheese sellers in the UK say that the ban is disproportionate. Cheese-mongers told The Grocer magazine that the ban is "costly, illogical and deeply frustrating", saying there is no risk to people from these cheeses. Advertisement Shane Holland, a cheese retailer based in London, told UK newspaper The Independent : "The bigger question is, what is the ban for? "We completely understand restricting the movement of live cattle. LSD is an infectious disease from cattle to cattle. But if we're talking about from cattle to milk, there's no cattle-to-human transmission at all. Even if there was the tiniest risk, it's not being consumed by cattle anyway." A Defra spokesperson stood by the ban, saying: 'This government will do whatever it takes to protect British farmers and their herds from disease,' adding that most Italian cheeses, such as Parmesan, Mozzarella and Gorgonzola, should be unaffected as they are largely pasteurised. However the UK is not the only country to impose a ban - Canada has also banned imports of unpasturised cheese from France, Italy and Switzerland. Advertisement Is this why Eurostar is telling me I can't take a ham sandwich on my journey from Paris to London? No, that's a different issue, it's because of an outbreak of foot and mouth disease in continental Europe. Germany detected an outbreak in January but has since been declared FMD-free, however subsequent outbreaks in Hungary and Slovakia have persisted. In response, the UK recently announced that it has banned imports of meat or dairy products from European countries where the virus has been detected, as well as Austria due to the outbreak in neighbouring Hungary. However travellers are being advised that meat and dairy products from all EU countries are banned, which is why you may have received an email from Eurostar or ferry companies if you have recently travelled from France to the UK. Foot and mouth disease does not affect humans but is highly contagious among cattle. A major outbreak in the UK in 2001 led to the culling of more than six million animals and cost the economy billions, devastating the livestock industry and tourism.

Sanofi buys UK's Vicebio for over €1bn to expand vaccine portfolio
Sanofi buys UK's Vicebio for over €1bn to expand vaccine portfolio

Euronews

time3 days ago

  • Euronews

Sanofi buys UK's Vicebio for over €1bn to expand vaccine portfolio

In the race to develop next-generation respiratory virus vaccines, French pharmaceutical company Sanofi has agreed to buy Vicebio Ltd., a privately-held biotechnology company headquartered in London, UK. Sanofi said there will be an initial cash payment of $1.15bn (€980 million) for the deal, 'with potential milestone payments of up to $450 million based on development and regulatory achievements'. 'We are excited to join Sanofi', said Emmanuel Hanon, Chief Executive Officer at Vicebio, in a statement. 'Their global scale and deep expertise in vaccine development provide the ideal environment to fully realise the potential of our innovative technology." With the acquisition, Sanofi gets Vicebio's early-stage combination vaccine candidate for two respiratory viruses, the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Respiratory infections, affecting millions globally, often appear as cold-like illnesses that could, in severe cases, lead to pneumonia. In respiratory medication, Sanofi already has several vaccines in its portfolio against flu and RSV prevention; this latest acquisition adds a non-mRNA vaccine to its pipeline. mRNA technology is relatively new for vaccines. It teaches the body how to make a protein that triggers an immune response to protect against a specific virus, instead of using a weakened or inactivated germ to trigger this reaction. With the current deal, Sanofi also gets access to Vicebio's Molecular Clamp technology, which stabilises viral proteins in their native shape, triggering a more effective immune response. This technology is expected to speed up vaccine development and simplify manufacturing and distribution. 'This acquisition furthers Sanofi's dedication to vaccine innovation with the potential to develop next-generation combination vaccines that could provide protection to older adults against multiple respiratory viruses with a single immunisation," said Jean-François Toussaint, global head of research and development vaccines at Sanofi. The transaction is expected to close by the end of 2025, and will not have a significant impact on Sanofi's financial guidance for 2025. The pharma giant's share price was down around 0.4% before 11:00 CEST in Paris.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store